Black Rock Inc. Sage Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,215,589 shares of SAGE stock, worth $28.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,215,589

Previous 4,892,162 6.61%

Holding current value

$28.3 Million

Previous $91.7 Million 38.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.58 - $17.9 $3.42 Million - $5.79 Million	323,427 Added 6.61%	5,215,589 $56.6 Million
Q1 2024 May 10, 2024	BUY	$18.62 - $26.95 $4.25 Million - $6.15 Million	228,262 Added 4.89%	4,892,162 $91.7 Million
Q4 2023 Feb 13, 2024	BUY	$17.1 - $22.26 $7.65 Million - $9.96 Million	447,305 Added 10.61%	4,663,900 $101 Million
Q3 2023 Nov 13, 2023	SELL	$16.75 - $48.98 $3.48 Million - $10.2 Million	-207,611 Reduced 4.69%	4,216,595 $86.8 Million
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $20.6 Million - $30.1 Million	-505,580 Reduced 10.26%	4,424,206 $208 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $723,969 - $904,622	19,425 Added 0.4%	4,929,786 $207 Million
Q4 2022 Feb 13, 2023	BUY	$32.2 - $43.61 $2.84 Million - $3.85 Million	88,298 Added 1.83%	4,910,361 $187 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $18.7 Million - $25.1 Million	580,250 Added 13.68%	4,822,063 $189 Million
Q2 2022 Aug 12, 2022	BUY	$27.52 - $37.99 $40.9 Million - $56.5 Million	1,487,597 Added 54.01%	4,241,813 $137 Million
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $774,536 - $1.15 Million	-25,221 Reduced 0.91%	2,754,216 $91.2 Million
Q4 2021 Feb 10, 2022	SELL	$37.06 - $47.11 $3.53 Million - $4.48 Million	-95,118 Reduced 3.31%	2,779,437 $118 Million
Q3 2021 Nov 09, 2021	BUY	$40.26 - $57.37 $968,534 - $1.38 Million	24,057 Added 0.84%	2,874,555 $127 Million
Q2 2021 Aug 11, 2021	BUY	$54.88 - $79.29 $156 Million - $226 Million	2,850,498 New	2,850,498 $162 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account